For research use only. Not for therapeutic Use.
20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1].
| Catalog Number | I032882 |
| CAS Number | 858557-69-4 |
| Synonyms | (2,6-dimethoxyphenyl)-[4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methanone |
| Molecular Formula | C23H25N3O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H25N3O4/c1-15-7-9-16(10-8-15)21-24-22(30-25-21)17-11-13-26(14-12-17)23(27)20-18(28-2)5-4-6-19(20)29-3/h4-10,17H,11-14H2,1-3H3 |
| InChIKey | MPMGADZKWJDRRX-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)C2=NOC(=N2)C3CCN(CC3)C(=O)C4=C(C=CC=C4OC)OC |
| Reference | [1]. Parlati F, et, al. Novel substrate for rpn 11 enzymatic activity. WO2006128196A2. |
